TAMPA, Fla., March 15, 2018 /PRNewswire/ — Intezyne, a clinical-stage biopharmaceutical company headquartered at the USF Tampa Bay Technology Incubator, announced that the company’s Chief Financial Officer, E. Russell McAllister, has been selected as its next President and Chief…
